Dexcom Inc
DXCM68.200USD
+0.020+0.03%
Handelsschluss 10/30, 16:00（ET）Kurse um 15 Minuten verzögert
26.75BMarktkapitalisierung
46.80KGV TTM
mehr Informationen über Dexcom Inc Unternehmen
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Dexcom Inc Informationen
BörsenkürzelDXCM
Name des UnternehmensDexcom Inc
IPO-datumApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Anzahl der mitarbeiter10300
WertpapierartOrdinary Share
GeschäftsjahresendeApr 14
Addresse6340 Sequence Dr
StadtSAN DIEGO
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl92121
Telefon18582000200
Websitehttps://www.dexcom.com/
BörsenkürzelDXCM
IPO-datumApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Führungskräfte von Dexcom Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
276.26K
+6.52%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.33K
-12.01%
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Independent Director
Independent Director
28.04K
+21.94%
Mr. Kyle Malady
Mr. Kyle Malady
Independent Director
Independent Director
22.67K
-2.86%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Independent Director
Independent Director
9.04K
+127.87%
Ms. Renee D. Gala
Ms. Renee D. Gala
Independent Director
Independent Director
6.88K
+20.30%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
276.26K
+6.52%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.33K
-12.01%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Distributor
977.80M
84.50%
Direct
179.30M
15.50%
Nach RegionUSD
Name
Umsatz
Anteil
United States
841.00M
72.68%
Outside of United states
316.10M
27.32%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Distributor
977.80M
84.50%
Direct
179.30M
15.50%
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Investment Management (US)
4.30%
Baillie Gifford & Co.
4.26%
Geode Capital Management, L.L.C.
2.75%
Andere
70.24%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Investment Management (US)
4.30%
Baillie Gifford & Co.
4.26%
Geode Capital Management, L.L.C.
2.75%
Andere
70.24%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.32%
Investment Advisor/Hedge Fund
28.54%
Research Firm
3.44%
Hedge Fund
3.01%
Pension Fund
2.02%
Bank and Trust
1.84%
Sovereign Wealth Fund
1.50%
Venture Capital
0.40%
Individual Investor
0.36%
Andere
2.55%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
2148
383.02M
97.67%
-30.18M
2025Q2
2212
390.97M
99.70%
-27.53M
2025Q1
2252
386.55M
98.59%
-25.17M
2024Q4
2220
380.88M
97.47%
-26.96M
2024Q3
2145
382.31M
97.83%
-30.58M
2024Q2
2115
397.02M
99.11%
-4.31M
2024Q1
2093
389.18M
98.33%
-19.87M
2023Q4
2081
398.01M
103.26%
+83.33K
2023Q3
1994
389.89M
100.89%
-11.88M
2023Q2
1952
389.17M
100.78%
-12.73M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
48.15M
12.28%
+859.71K
+1.82%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.25M
6.18%
-475.12K
-1.92%
Jun 30, 2025
State Street Investment Management (US)
16.86M
4.3%
+175.27K
+1.05%
Jun 30, 2025
Baillie Gifford & Co.
16.71M
4.26%
+2.53M
+17.81%
Jun 30, 2025
Geode Capital Management, L.L.C.
10.77M
2.75%
+358.62K
+3.45%
Jun 30, 2025
Jennison Associates LLC
11.52M
2.94%
+994.30K
+9.45%
Jun 30, 2025
Sands Capital Management, LLC
9.95M
2.54%
-466.21K
-4.48%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
8.03M
2.05%
-28.35K
-0.35%
Aug 31, 2025
Nuveen LLC
7.30M
1.86%
-549.07K
-7.00%
Jun 30, 2025
MFS Investment Management
6.49M
1.65%
+3.30M
+103.55%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Mon, Oct 6
Aktualisiert: Mon, Oct 6
Name
Anteil
First Trust Nasdaq Lux Digi Health Solutions ETF
6.79%
Langar Global HealthTech ETF
5.33%
Global X Internet of Things ETF
5.24%
Global X HealthTech ETF
3.89%
Fidelity Digital Health ETF
3.79%
Harbor Health Care ETF
3.48%
iShares U.S. Medical Devices ETF
3.39%
Touchstone Sands Capital US Select Growth ETF
3.06%
Goldman Sachs Future Health Care Equity ETF
2.68%
Motley Fool Global Opportunities ETF
2.43%
Mehr Anzeigen
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil6.79%
Langar Global HealthTech ETF
Anteil5.33%
Global X Internet of Things ETF
Anteil5.24%
Global X HealthTech ETF
Anteil3.89%
Fidelity Digital Health ETF
Anteil3.79%
Harbor Health Care ETF
Anteil3.48%
iShares U.S. Medical Devices ETF
Anteil3.39%
Touchstone Sands Capital US Select Growth ETF
Anteil3.06%
Goldman Sachs Future Health Care Equity ETF
Anteil2.68%
Motley Fool Global Opportunities ETF
Anteil2.43%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Mar 28, 2022
Split
1→4
Datum
Art
Verhältnis
Mar 28, 2022
Split
1→4
